Who We Are:
Calico (Calico Life Sciences LLC) is an Alphabet-founded research and development company whose mission is to harness advanced technologies and model systems to increase our understanding of the biology that controls human aging. Calico will use that knowledge to devise interventions that enable people to lead longer and healthier lives. Calico’s highly innovative technology labs, its commitment to curiosity-driven discovery science, and, with academic and industry partners, its vibrant drug-development pipeline, together create an inspiring and exciting place to catalyze and enable medical breakthroughs.

Position Description:

The Associate Director/Director, Clinical Pharmacology role at Calico is responsible for the planning and execution of the translational and early clinical development plans and protocols of several projects related to Calico’s mission to improve human healthspan by understanding aging and age-related diseases. The successful candidate would participate/drive the development of early clinical strategies, especially first-in-human, clinical pharmacology, and exploratory clinical biomarker studies for assigned program(s)/indication(s) and should be able to support novel and innovative clinical plans while ensuring a positive and collaborative team environment.

Responsibilities:

  • In coordination with the Head of Clinical Science and/or Medical Director(s), leads or represents the Clinical Pharmacology function in cross-functional project and study teams that develop and execute the early clinical development plan to translate preclinical mechanistic data to humans for novel aging-related targets
  • Design and oversee execution of the Clinical Pharmacology strategy for portfolio programs, including first-in-human protocols to determine initial safety, tolerability, and pharmacokinetics and other Clinical Pharmacology studies to support early development, including ADME, DDI, TQT, Renal and Hepatic Impairment studies
  • Contributes to the design and execution of experimental medicine studies to demonstrate proof-of-mechanism of novel targets in aging and age-related diseases
  • Contributes to the design and execution of Phase 2 studies, including the dose selection strategy
  • Primary author or contributing author for assigned clinical protocols from Phase 0 through Phase 2, collaborating with and coordinating other functions required for protocol development, including Research, Biomarkers, Clinical Operations, Regulatory Affairs, Clinical Biostatistics, Safety Science, and Toxicology
  • Authors, contributes to, or reviews Clinical, Regulatory and relevant study documents including Investigational Brochures, Clinical Study Reports, Statistical Analysis Plans, Operations/Technical Manuals, IND/CTAs, case report forms and data tables, listings and figures
  • Trains CROs and study site personnel on assigned protocols and addresses protocol queries as they arise
  • Participates in the assessment of CROs and study vendors

Position Requirements:

  • Advanced degree in an area of discipline relevant for pharmaceutical development (PhD, PharmD, MS)
  • Modeling and Simulation expertise preferred
  • At least 8 years of experience in early clinical drug development in the biotech/pharmaceutical industry performing the responsibilities described above  
  • Experience in early clinical trial methodology (Phase 0, Phase 1, Phase 2) and knowledge of drug development process and clinical deliverables from IND through clinical proof-of-concept
  • Experience in designing and overseeing execution of first-in-human, ADME, DDI, TQT, hepatic and renal impairment studies
  • Experience in overseeing and interpreting pharmacokinetic parameters in the studies outlined above
  • Experience in overseeing clinical pharmacology and preclinical pharmacology functions at CROs or development partners
  • Excellent understanding of clinically relevant ICH GCP guidance, FDA and EMA regulations
  • Ability to perform role responsibilities largely independently
  • Proven leadership skills and ability to bring out the best in others on a cross-functional team
  • Able to provide effective leadership through influence across organizations on partnered programs
  • Detail-oriented mindset with excellent oral and written communication skills 
  • Must be willing to work onsite at least 4 days a week

The estimated base salary range for this role is $225,000- $295,000. Actual pay will be based on a number of factors including experience and qualifications. This position is also eligible for two annual cash bonuses.




 

Apply for this Job

* Required
resume chosen  
Dropbox
(File types: pdf, doc, docx, txt, rtf)
Cancel
cover_letter chosen  
Dropbox
(File types: pdf, doc, docx, txt, rtf)
Cancel

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Calico ’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Voluntary Self-Identification of Disability

Form CC-305
Page 1 of 1
OMB Control Number 1250-0005
Expires 04/30/2026

Why are you being asked to complete this form?

We are a federal contractor or subcontractor. The law requires us to provide equal employment opportunity to qualified people with disabilities. We have a goal of having at least 7% of our workers as people with disabilities. The law says we must measure our progress towards this goal. To do this, we must ask applicants and employees if they have a disability or have ever had one. People can become disabled, so we need to ask this question at least every five years.

Completing this form is voluntary, and we hope that you will choose to do so. Your answer is confidential. No one who makes hiring decisions will see it. Your decision to complete the form and your answer will not harm you in any way. If you want to learn more about the law or this form, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp.

How do you know if you have a disability?

A disability is a condition that substantially limits one or more of your “major life activities.” If you have or have ever had such a condition, you are a person with a disability. Disabilities include, but are not limited to:

  • Alcohol or other substance use disorder (not currently using drugs illegally)
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, HIV/AIDS
  • Blind or low vision
  • Cancer (past or present)
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or serious difficulty hearing
  • Diabetes
  • Disfigurement, for example, disfigurement caused by burns, wounds, accidents, or congenital disorders
  • Epilepsy or other seizure disorder
  • Gastrointestinal disorders, for example, Crohn's Disease, irritable bowel syndrome
  • Intellectual or developmental disability
  • Mental health conditions, for example, depression, bipolar disorder, anxiety disorder, schizophrenia, PTSD
  • Missing limbs or partially missing limbs
  • Mobility impairment, benefiting from the use of a wheelchair, scooter, walker, leg brace(s) and/or other supports
  • Nervous system condition, for example, migraine headaches, Parkinson’s disease, multiple sclerosis (MS)
  • Neurodivergence, for example, attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, dyslexia, dyspraxia, other learning disabilities
  • Partial or complete paralysis (any cause)
  • Pulmonary or respiratory conditions, for example, tuberculosis, asthma, emphysema
  • Short stature (dwarfism)
  • Traumatic brain injury

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.

Enter the verification code sent to to confirm you are not a robot, then submit your application.

This application was flagged as potential bot traffic. To resubmit your application, turn off any VPNs, clear the browser's cache and cookies, or try another browser. If you still can't submit it, contact our support team through the help center.